Literature DB >> 6106124

Cimetidine in primary hyperparathyroidism.

S Ljunghall, G Akerström, C Rudberg, L Wide, H Johansson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6106124     DOI： 10.1016/s0140-6736(80)91916-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  Calcif Tissue Int       Date:  1987-02       Impact factor: 4.333

2.  Effect of combination therapy with cimetidine and pirenzepine on plasma parathyroid hormone and calcitonin levels in hemodialyzed patients.

Authors:  E Minar; J Zazgornik; R Dudczak; L Marosi
Journal:  Klin Wochenschr       Date:  1984-06-01

3.  Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

4.  The effects of cimetidine on serum calcium and parathyroid hormone levels in primary hyperparathyroidism.

Authors:  R A Fisken; R Wilkinson; D A Heath
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.